| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 99 | 110 | 5,950 | $270 | $2.6M |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 134 | 140 | 2,830 | $150 | $1.1M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 19 | 20 | 190 | $1,670 | $956.2K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 6 | 10 | 3,400 | $70 | $683.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 71 | 100 | 3,660 | $100 | $635.7K |
| 96366 | The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease. | 73 | 70 | 2,010 | $210 | $620.1K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 35 | 40 | 1,040 | $390 | $518.8K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 91 | 120 | 2,040 | $30 | $464.9K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 91 | 120 | 2,020 | $30 | $441.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 17 | 1,820 | 480 | $60 | $379.6K |